NeuroX1

About:

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

Top Investors: Techstars, Drive Capital, Capital Factory, Trousdale Ventures, Vibe Capital

Description:

NeuroX1 is a computational drug design startup building a platform to identify drivers of neurodegenerative/neurological diseases then using Chiron, a propritary generative chemistry platform, designs novel compounds for those diseases.

Total Funding Amount:

$1.97M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2021-11-18

Contact Email:

hello(AT)neurox1.com

Founders:

Conner Myers, Lucas Myers, Maxwell Dordevic

Number of Employees:

11-50

Last Funding Date:

2024-03-15

IPO Status:

Private

Industries: